Partner: Yousef Daneshmandpour


Ostatnie publikacje
1.Sabaie H., Moghaddam Marziyeh M., Moghaddam Madiheh M., Amirinejad N., Asadi Mohammad R., Daneshmandpour Y., Hussen Bashdar M., Taheri M., Rezazadeh M., Long non-coding RNA-associated competing endogenous RNA axes in the olfactory epithelium in schizophrenia: a bioinformatics analysis, Scientific Reports, ISSN: 2045-2322, DOI: 10.1038/s41598-021-04326-0, Vol.11, pp.24497-1-9, 2021

Streszczenie:

The etiology of schizophrenia (SCZ), as a serious mental illness, is unknown. The significance of genetics in SCZ pathophysiology is yet unknown, and newly identified mechanisms involved in the regulation of gene transcription may be helpful in determining how these changes affect SCZ development and progression. In the current work, we used a bioinformatics approach to describe the role of long non-coding RNA (lncRNA)-associated competing endogenous RNAs (ceRNAs) in the olfactory epithelium (OE) samples in order to better understand the molecular regulatory processes implicated in SCZ disorders in living individuals. The Gene Expression Omnibus database was used to obtain the OE microarray dataset (GSE73129) from SCZ sufferers and control subjects, which contained information about both lncRNAs and mRNAs. The limma package of R software was used to identify the differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs). RNA interaction pairs were discovered using the Human MicroRNA Disease Database, DIANA-LncBase, and miRTarBase databases. In this study, the Pearson correlation coefficient was utilized to find positive correlations between DEmRNAs and DElncRNAs in the ceRNA network. Eventually, lncRNA-associated ceRNA axes were developed based on co-expression relations and DElncRNA-miRNA-DEmRNA interactions. This work found six potential DElncRNA-miRNA-DEmRNA loops in SCZ pathogenesis, including, SNTG2-AS1/hsa-miR-7-5p/SLC7A5, FLG-AS1/hsa-miR-34a-5p/FOSL1, LINC00960/hsa-miR-34a-5p/FOSL1, AQP4-AS1/hsa-miR-335-5p/FMN2, SOX2-OT/hsa-miR-24-3p/NOS3, and CASC2/hsa-miR-24-3p/NOS3. According to the findings, ceRNAs in OE might be promising research targets for studying SCZ molecular mechanisms. This could be a great opportunity to examine different aspects of neurodevelopment that may have been hampered early in SCZ patients.

Afiliacje autorów:

Sabaie H.-other affiliation
Moghaddam Marziyeh M.-other affiliation
Moghaddam Madiheh M.-other affiliation
Amirinejad N.-other affiliation
Asadi Mohammad R.-other affiliation
Daneshmandpour Y.-other affiliation
Hussen Bashdar M.-other affiliation
Taheri M.-other affiliation
Rezazadeh M.-other affiliation
140p.
2.Sabaie H., Amirinejad N., Asadi Mohammad R., Jalaiei A., Daneshmandpour Y., Rezaei O., Taheri M., Rezazadeh M., Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review, Frontiers in Aging Neuroscience, ISSN: 1663-4365, DOI: 10.3389/fnagi.2021.742242, Vol.13, pp.742242-1-15, 2021

Streszczenie:

Alzheimer’s disease (AD) is a heterogeneous degenerative brain disorder with a rising prevalence worldwide. The two hallmarks that characterize the AD pathophysiology are amyloid plaques, generated via aggregated amyloid β, and neurofibrillary tangle, generated via accumulated phosphorylated tau. At the post-transcriptional and transcriptional levels, the regulatory functions of non-coding RNAs, in particular long non-coding RNAs (lncRNAs), have been ascertained in gene expressions. It is noteworthy that a number of lncRNAs feature a prevalent role in their potential of regulating gene expression through modulation of microRNAs via a process called the mechanism of competing endogenous RNA (ceRNA). Given the multifactorial nature of ceRNA interaction networks, they might be advantageous in complex disorders (e.g., AD) investigations at the therapeutic targets level. We carried out scoping review in this research to analyze validated loops of ceRNA in AD and focus on ceRNA axes associated with lncRNA. This scoping review was performed according to a six-stage methodology structure and PRISMA guideline. A systematic search of seven databases was conducted to find eligible articles prior to July 2021. Two reviewers independently performed publications screening and data extraction, and quantitative and qualitative analyses were conducted. Fourteen articles were identified that fulfill the inclusion criteria. Studies with different designs reported nine lncRNAs that were experimentally validated to act as ceRNA in AD in human-related studies, including BACE1-AS, SNHG1, RPPH1, NEAT1, LINC00094, SOX21-AS1, LINC00507, MAGI2-AS3, and LINC01311. The BACE1-AS/BACE1 was the most frequent ceRNA pair. Among miRNAs, miR-107 played a key role by regulating three different loops. Understanding the various aspects of this regulatory mechanism can help elucidate the unknown etiology of AD and provide new molecular targets for use in therapeutic and clinical applications.

Słowa kluczowe:

Alzheimer’s disease,antisense oligonucleotides,competing endogenous RNA,long non-coding RNA,miRNA sponge

Afiliacje autorów:

Sabaie H.-other affiliation
Amirinejad N.-other affiliation
Asadi Mohammad R.-other affiliation
Jalaiei A.-other affiliation
Daneshmandpour Y.-other affiliation
Rezaei O.-other affiliation
Taheri M.-other affiliation
Rezazadeh M.-other affiliation